医生诊室诊断市场 - 全球产业规模、份额、趋势、机会及预测（按产品类型、应用、地区和竞争格局划分，2021-2031年）

全球医师诊间诊断市场预计将从 2025 年的 2.2934 亿美元成长到 2031 年的 5.0632 亿美元，复合年增长率为 14.11%。

这些诊断设备包括直接在医师诊疗室使用的医疗检测和系统，可提供即时结果，从而加速临床决策。市场成长的主要驱动因素是慢性病盛行率的上升、对快速诊断结果日益增长的需求以及医疗保健结构向分散化方向的转变。日益加重的疾病负担要求在基层医疗进行频繁的监测和检测，以便有效管理长期疾病。例如，国际糖尿病联盟 (IDF) 报告称，到 2024 年，全球约有 5.89 亿成年人将患有糖尿病，这凸显了在社区提供便利诊断解决方案的迫切需求。

然而，复杂的法规环境和报销压力严重阻碍了市场扩张。製造商必须遵守照护现场设备严格的核准程序，而医疗服务提供者则经常面临较低的报销率和严格的诊内检测应用限制。这些经济和合规方面的障碍会抑制小规模诊所采用新技术，并减缓全球诊所诊断能力的整体提升。

市场驱动因素

慢性病和文明病发生率的上升是全球临床诊断市场的主要驱动力。随着心血管疾病和糖尿病等疾病的日益普遍，基层医疗迫切需要持续、便捷的监测，以预防併发症。日益加重的疾病负担促使诊所采用诊断工具，使医生能够即时调整治疗方案，从而减少患者就诊次数。例如，雅培公司在2025年10月发布的「2025年第三季」财报中指出，持续血糖监测设备（对糖尿病这种文明病的管理至关重要）的销售额增长了20.5%，达到20亿美元，这表明人们对临床监测技术的依赖性日益增强。

此外，快速、符合CLIA豁免照护现场设备的科技进步正在使复杂的检测流程去中心化，从而加速市场成长。侧向层析检测和分子诊断技术的创新使得以往仅限于中心检查室的高级检测能够在诊所进行，显着缩短了检测结果的报告时间。这种转变使得临床决策能够即时做出，并透过提供一站式医疗服务提高了患者满意度。根据罗氏公司于2025年1月发布的“2024财年全年业绩报告”，该公司核心诊断业务增长了8%，这得益于各领域对分子诊断和免疫诊断解决方案的强劲需求。同样，Quest Diagnostics公司在2025年公布的2024财年全年销售额为98.7亿美元，反映出诊断服务在整个医疗保健流程中持续维持着较高的利用率。

市场挑战

复杂的监管环境和报销限制严重限制了医生诊间诊断市场的扩张。製造商需要经过严格的照护现场设备核准流程，这不仅延缓了产品进入市场，也增加了研发成本。同时，医疗机构往往面临报销率下降和诊室内检测项目保险覆盖范围受限的困境。当保险支付无法涵盖诊断设备的营运成本时，医疗机构便失去了采用这些技术的经济奖励，迫使许多基层医疗诊所放弃投资建设内部检测能力，转而选择外包检测服务。

近期联邦支付结构的调整进一步加剧了这些财务压力，直接影响了医疗服务提供者的收入。据美国医学会 (AMA) 称，2024 年联邦医疗保险医师收费标准的转换係数将比去年同期下降 3.37%。报销水准的降低给医疗机构带来了严峻的挑战，他们必须在应对诊断合规和设备维护等高昂营运成本的同时，承受这些收入减少的影响。因此，这种财务不稳定限制了小规模医疗机构的购买力，并阻碍了诊断系统的整体普及。

市场趋势

全球临床诊断市场正经历着向多重病原体检测模式的转变，这一趋势正在重塑市场模式。此模式能够从单一患者检体同时检测多种传染性病原体。它正日益取代传统的单靶点检测，尤其是在呼吸道疾病领域，因为呼吸道合胞病毒（RSV）、流感和新冠病毒（COVID-19）的症状经常重迭。采用整合检测方案使基层医疗提供者能够在一次就诊中快速区分共同流行的病毒，从而简化临床工作流程并确保抗病毒药物处方的准确性。主要企业的财务成功也印证了这个趋势。根据丹纳赫公司于2025年2月发布的《2024年第四季财报》，Sepeed公司的呼吸系统业务收入达到约5.5亿美元，超出预期，这主要得益于分散式医疗机构对其四组分多重检测产品的需求不断增长。

同时，携带式诊断平台的微型化也提高了可在诊疗现场直接进行的医学检测的复杂性。製造商正在推出符合CLIA豁免标准的紧凑型设备，这些设备将先进的分子诊断功能整合到可放置在医生诊台或办公桌上的小型设备中。这项技术进步使得即使是小规模诊所也能避免在中心实验室的物流延误，并在几分钟内获得检查室级的检测结果，从而支持即时治疗决策。例如，生物梅里埃公司在2025年3月发布的2024年财务报告中指出，其紧凑型综合症检测平台SPOTFIRE系统的销售额已达到9500万欧元，远超公司最初的年度目标，这便是这些解决方案迅速普及的一个例证。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球医师诊间诊断市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品类型（就地检验(POCT) 设备、临床化学分析仪、免疫检测系统、分子诊断、尿液分析系统）
  • 依应用领域（感染疾病、心血管疾病、代谢性疾病、癌症诊断、怀孕和不孕症检测）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美医师诊间诊断市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲医师诊间诊断市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区医师诊间诊断市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲医生诊室诊断市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲医师诊间诊断市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球医师诊间诊断市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Abbott Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Sysmex America, Inc.
• Bio-Rad Laboratories, Inc.
• BioMerieux SA
• Beckman Coulter, Inc.
• Trinity Biotech Plc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Physician Office Diagnostic Market is projected to expand from USD 229.34 Million in 2025 to USD 506.32 Million by 2031, reflecting a CAGR of 14.11%. These diagnostics consist of medical tests and systems utilized directly within a doctor's clinic, offering immediate results that expedite clinical decision-making. The market's growth is primarily driven by the increasing prevalence of chronic diseases, a growing necessity for rapid diagnostic turnaround times, and a structural transition toward decentralized healthcare. This rising disease burden requires frequent monitoring and testing at the primary care level to effectively manage long-term conditions; for instance, the International Diabetes Federation reported that approximately 589 million adults globally were living with diabetes in 2024, underscoring the urgent need for accessible diagnostic solutions in community settings.

However, market expansion is significantly impeded by a complicated regulatory environment and reimbursement pressures. Manufacturers are required to navigate strict approval procedures for point-of-care devices, while healthcare providers frequently face reducing reimbursement rates or stringent coverage restrictions for in-office tests. These economic and compliance hurdles create disincentives for smaller practices to adopt new technologies, which can potentially decelerate the overall advancement of diagnostic capabilities in physician offices worldwide.

Market Driver

The rising incidence of chronic and lifestyle-related diseases acts as a major catalyst for the Global Physician Office Diagnostic Market. As conditions such as cardiovascular disorders and diabetes become more widespread, there is a critical need for consistent, accessible monitoring within primary care to avert complications. This increasing disease burden promotes the adoption of in-office diagnostic tools that enable practitioners to modify treatment plans in real-time, thereby decreasing the necessity for hospital visits. For example, Abbott reported in its 'Third Quarter 2025 Financial Results' in October 2025 that sales of continuous glucose monitors, which are essential for managing lifestyle-related diabetes, increased by 20.5% to reach $2 billion, demonstrating a deepened reliance on office-supported monitoring technologies.

Furthermore, technological advancements in rapid, CLIA-waived point-of-care devices are accelerating market growth by decentralizing complex testing procedures. Innovations in lateral flow assays and molecular diagnostics now permit physician offices to conduct sophisticated tests that were previously limited to central laboratories, significantly shortening turnaround times. This shift facilitates immediate clinical decision-making and improves patient satisfaction by offering one-stop medical services. Roche's January 2025 'Full Year 2024 Results' indicated that its Diagnostics Division's base business grew by 8%, fueled by robust demand for molecular and immunodiagnostic solutions in various settings. Similarly, Quest Diagnostics reported full-year 2024 revenues of $9.87 billion in 2025, reflecting the sustained high utilization of diagnostic services across the healthcare continuum.

Market Challenge

The expansion of the physician office diagnostic market is significantly restricted by a complex regulatory landscape combined with reimbursement constraints. Manufacturers endure rigorous approval processes for point-of-care devices, which delays market entry and escalates development costs. Simultaneously, healthcare providers often contend with declining reimbursement rates or strict coverage limitations for tests performed in the office. When insurance payments fail to cover the operational costs of diagnostic equipment, physician practices face a financial disincentive to adopt these technologies, forcing many primary care clinics to outsource testing rather than investing in on-site capabilities.

Recent adjustments in federal payment structures further evidence these financial pressures, directly affecting provider revenue. According to the American Medical Association, the Medicare Physician Fee Schedule conversion factor saw a reduction of 3.37 percent in 2024 compared to the prior year. Such cuts in reimbursement levels create a difficult environment for physician offices, which must absorb these reductions while managing the high overhead associated with maintaining diagnostic compliance and equipment. Consequently, this financial instability limits the purchasing power of smaller practices and hampers the overall adoption of diagnostic systems.

Market Trends

The Global Physician Office Diagnostic Market is being reshaped by a shift toward Syndromic Multiplex Pathogen Testing, which allows for the simultaneous detection of multiple infectious agents from a single patient sample. This method is replacing traditional single-target assays, especially for respiratory conditions where symptoms of RSV, influenza, and COVID-19 frequently overlap. By employing consolidated panels, primary care providers can rapidly distinguish between co-circulating viruses during a single visit, streamlining clinical workflows and ensuring accurate antiviral prescriptions. The financial success of major players highlights this trend; according to Danaher's February 2025 'Fourth Quarter 2024 Earnings Results,' Cepheid's respiratory revenue hit approximately $550 million, surpassing expectations due to strong demand for their 4-in-1 multiplex test in decentralized settings.

Simultaneously, the miniaturization of handheld diagnostic platforms is increasing the complexity of medical tests that can be performed directly at the point of care. Manufacturers are launching compact, CLIA-waived devices that condense sophisticated molecular capabilities into small-footprint instruments suitable for a clinic counter or doctor's desk. This technological evolution enables smaller practices to bypass the logistical delays of central reference laboratories, delivering lab-quality results within minutes to support immediate treatment decisions. Highlighting the rapid uptake of these solutions, bioMerieux reported in its March 2025 '2024 Financial Results' that sales of the SPOTFIRE system, a compact syndromic testing platform, reached €95 million, significantly outperforming the company's initial annual targets.

Key Market Players

• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Abbott Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Sysmex America, Inc.
• Bio-Rad Laboratories, Inc.
• BioMerieux SA
• Beckman Coulter, Inc.
• Trinity Biotech Plc.

Report Scope

In this report, the Global Physician Office Diagnostic Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Physician Office Diagnostic Market, By Product Type

• Point-of-Care Testing (POCT) Devices
• Clinical Chemistry Analyzers
• Immunoassay Systems
• Molecular Diagnostics
• Urinalysis Systems

Physician Office Diagnostic Market, By Application

• Infectious Diseases
• Cardiovascular Disorders
• Metabolic Disorders
• Cancer Diagnosis
• Pregnancy
• Fertility Testing

Physician Office Diagnostic Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Physician Office Diagnostic Market.

Available Customizations:

Global Physician Office Diagnostic Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Physician Office Diagnostic Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Point-of-Care Testing (POCT) Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, Urinalysis Systems)
  • 5.2.2. By Application (Infectious Diseases, Cardiovascular Disorders, Metabolic Disorders, Cancer Diagnosis, Pregnancy, Fertility Testing)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Physician Office Diagnostic Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Physician Office Diagnostic Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Physician Office Diagnostic Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Physician Office Diagnostic Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application

7. Europe Physician Office Diagnostic Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Physician Office Diagnostic Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
  • 7.3.2. France Physician Office Diagnostic Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Physician Office Diagnostic Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Physician Office Diagnostic Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Physician Office Diagnostic Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application

8. Asia Pacific Physician Office Diagnostic Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Physician Office Diagnostic Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Physician Office Diagnostic Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Physician Office Diagnostic Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Physician Office Diagnostic Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Physician Office Diagnostic Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application

9. Middle East & Africa Physician Office Diagnostic Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Physician Office Diagnostic Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Physician Office Diagnostic Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Physician Office Diagnostic Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application

10. South America Physician Office Diagnostic Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Physician Office Diagnostic Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Physician Office Diagnostic Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Physician Office Diagnostic Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Physician Office Diagnostic Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. F. Hoffmann-La Roche Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Siemens Healthineers AG
• 15.3. Abbott Laboratories Inc.
• 15.4. Thermo Fisher Scientific Inc.
• 15.5. Danaher Corporation
• 15.6. Sysmex America, Inc.
• 15.7. Bio-Rad Laboratories, Inc.
• 15.8. BioMerieux SA
• 15.9. Beckman Coulter, Inc.
• 15.10. Trinity Biotech Plc.

16. Strategic Recommendations

17. About Us & Disclaimer